Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.
Identifieur interne : 003446 ( Ncbi/Merge ); précédent : 003445; suivant : 003447Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.
Auteurs : Aurélie Mbeutcha [Autriche] ; Morgan Rouprêt [France] ; Ashish M. Kamat [États-Unis] ; Pierre I. Karakiewicz [Canada] ; Nathan Lawrentschuk [Australie] ; Giacomo Novara [Italie] ; Jay D. Raman [États-Unis] ; Christian Seitz [Autriche] ; Evanguelos Xylinas [France] ; Shahrokh F. Shariat [Autriche]Source :
- World journal of urology [ 1433-8726 ] ; 2017.
Descripteurs français
- KwdFr :
- Carcinome transitionnel (), Carcinome transitionnel (anatomopathologie), Carcinome transitionnel (métabolisme), Carcinome transitionnel (épidémiologie), Facteurs de l'âge, Grading des tumeurs, Humains, Hydronéphrose (épidémiologie), Invasion tumorale, Marqueurs biologiques tumoraux (métabolisme), Métastase lymphatique, Noeuds lymphatiques (anatomopathologie), Obésité (épidémiologie), Pelvis rénal (), Pelvis rénal (anatomopathologie), Prise de décision clinique, Pronostic, Stade de la tumeur, Survie sans rechute, Tabagisme (épidémiologie), Tumeurs de l'uretère (), Tumeurs de l'uretère (anatomopathologie), Tumeurs de l'uretère (métabolisme), Tumeurs de l'uretère (épidémiologie), Tumeurs du rein (), Tumeurs du rein (anatomopathologie), Tumeurs du rein (métabolisme), Tumeurs du rein (épidémiologie), Tumeurs primitives multiples (), Tumeurs primitives multiples (anatomopathologie), Tumeurs primitives multiples (métabolisme), Tumeurs primitives multiples (épidémiologie), Épithélioma in situ (épidémiologie), Évaluation des risques.
- MESH :
- anatomopathologie : Carcinome transitionnel, Noeuds lymphatiques, Pelvis rénal, Tumeurs de l'uretère, Tumeurs du rein, Tumeurs primitives multiples.
- métabolisme : Carcinome transitionnel, Marqueurs biologiques tumoraux, Tumeurs de l'uretère, Tumeurs du rein, Tumeurs primitives multiples.
- épidémiologie : Carcinome transitionnel, Hydronéphrose, Obésité, Tabagisme, Tumeurs de l'uretère, Tumeurs du rein, Tumeurs primitives multiples, Épithélioma in situ.
- Carcinome transitionnel, Facteurs de l'âge, Grading des tumeurs, Humains, Invasion tumorale, Métastase lymphatique, Pelvis rénal, Prise de décision clinique, Pronostic, Stade de la tumeur, Survie sans rechute, Tumeurs de l'uretère, Tumeurs du rein, Tumeurs primitives multiples, Évaluation des risques.
English descriptors
- KwdEn :
- Age Factors, Biomarkers, Tumor (metabolism), Carcinoma in Situ (epidemiology), Carcinoma, Transitional Cell (epidemiology), Carcinoma, Transitional Cell (metabolism), Carcinoma, Transitional Cell (pathology), Carcinoma, Transitional Cell (therapy), Clinical Decision-Making, Disease-Free Survival, Humans, Hydronephrosis (epidemiology), Kidney Neoplasms (epidemiology), Kidney Neoplasms (metabolism), Kidney Neoplasms (pathology), Kidney Neoplasms (therapy), Kidney Pelvis (pathology), Kidney Pelvis (surgery), Lymph Nodes (pathology), Lymphatic Metastasis, Neoplasm Grading, Neoplasm Invasiveness, Neoplasm Staging, Neoplasms, Multiple Primary (epidemiology), Neoplasms, Multiple Primary (metabolism), Neoplasms, Multiple Primary (pathology), Neoplasms, Multiple Primary (therapy), Obesity (epidemiology), Prognosis, Risk Assessment, Smoking (epidemiology), Ureteral Neoplasms (epidemiology), Ureteral Neoplasms (metabolism), Ureteral Neoplasms (pathology), Ureteral Neoplasms (therapy).
- MESH :
- chemical , metabolism : Biomarkers, Tumor.
- epidemiology : Carcinoma in Situ, Carcinoma, Transitional Cell, Hydronephrosis, Kidney Neoplasms, Neoplasms, Multiple Primary, Obesity, Smoking, Ureteral Neoplasms.
- metabolism : Carcinoma, Transitional Cell, Kidney Neoplasms, Neoplasms, Multiple Primary, Ureteral Neoplasms.
- pathology : Carcinoma, Transitional Cell, Kidney Neoplasms, Kidney Pelvis, Lymph Nodes, Neoplasms, Multiple Primary, Ureteral Neoplasms.
- surgery : Kidney Pelvis.
- therapy : Carcinoma, Transitional Cell, Kidney Neoplasms, Neoplasms, Multiple Primary, Ureteral Neoplasms.
- Age Factors, Clinical Decision-Making, Disease-Free Survival, Humans, Lymphatic Metastasis, Neoplasm Grading, Neoplasm Invasiveness, Neoplasm Staging, Prognosis, Risk Assessment.
Abstract
Upper tract urothelial carcinoma (UTUC) is a rare and heterogeneous disease. Several clinical and biological prognostic factors have been identified in multi-institutional collaborative works with the aim of helping decision-making in pursuit of tailored individual patient care. This review provides an overview of these existing prognostic factors and predictive tools for the management of patients with UTUC.
DOI: 10.1007/s00345-016-1826-2
PubMed: 27101100
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000F74
- to stream PubMed, to step Curation: 000F71
- to stream PubMed, to step Checkpoint: 000F71
Links to Exploration step
pubmed:27101100Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.</title><author><name sortKey="Mbeutcha, Aurelie" sort="Mbeutcha, Aurelie" uniqKey="Mbeutcha A" first="Aurélie" last="Mbeutcha">Aurélie Mbeutcha</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author><author><name sortKey="Roupret, Morgan" sort="Roupret, Morgan" uniqKey="Roupret M" first="Morgan" last="Rouprêt">Morgan Rouprêt</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Pitié-Salpétrière Hospital, APHP, University Paris VI, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Urology, Pitié-Salpétrière Hospital, APHP, University Paris VI, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Kamat, Ashish M" sort="Kamat, Ashish M" uniqKey="Kamat A" first="Ashish M" last="Kamat">Ashish M. Kamat</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Karakiewicz, Pierre I" sort="Karakiewicz, Pierre I" uniqKey="Karakiewicz P" first="Pierre I" last="Karakiewicz">Pierre I. Karakiewicz</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, University of Montreal Health Center, Montreal, QC, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Urology, University of Montreal Health Center, Montreal, QC</wicri:regionArea><wicri:noRegion>QC</wicri:noRegion></affiliation></author><author><name sortKey="Lawrentschuk, Nathan" sort="Lawrentschuk, Nathan" uniqKey="Lawrentschuk N" first="Nathan" last="Lawrentschuk">Nathan Lawrentschuk</name><affiliation wicri:level="4"><nlm:affiliation>Department of Surgical Oncology, Peter MacCallum Cancer Centre and Department of Surgery/Olivia Newton John Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Surgical Oncology, Peter MacCallum Cancer Centre and Department of Surgery/Olivia Newton John Cancer Centre, University of Melbourne, Melbourne, VIC</wicri:regionArea><orgName type="university">Université de Melbourne</orgName><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Novara, Giacomo" sort="Novara, Giacomo" uniqKey="Novara G" first="Giacomo" last="Novara">Giacomo Novara</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Oncology, and Gastroenterology - Urology Clinic, University of Padua, Padua, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Surgery, Oncology, and Gastroenterology - Urology Clinic, University of Padua, Padua</wicri:regionArea><wicri:noRegion>Padua</wicri:noRegion></affiliation></author><author><name sortKey="Raman, Jay D" sort="Raman, Jay D" uniqKey="Raman J" first="Jay D" last="Raman">Jay D. Raman</name><affiliation wicri:level="2"><nlm:affiliation>Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Seitz, Christian" sort="Seitz, Christian" uniqKey="Seitz C" first="Christian" last="Seitz">Christian Seitz</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author><author><name sortKey="Xylinas, Evanguelos" sort="Xylinas, Evanguelos" uniqKey="Xylinas E" first="Evanguelos" last="Xylinas">Evanguelos Xylinas</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Shariat, Shahrokh F" sort="Shariat, Shahrokh F" uniqKey="Shariat S" first="Shahrokh F" last="Shariat">Shahrokh F. Shariat</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria. sfshariat@gmail.com.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27101100</idno><idno type="pmid">27101100</idno><idno type="doi">10.1007/s00345-016-1826-2</idno><idno type="wicri:Area/PubMed/Corpus">000F74</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F74</idno><idno type="wicri:Area/PubMed/Curation">000F71</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F71</idno><idno type="wicri:Area/PubMed/Checkpoint">000F71</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F71</idno><idno type="wicri:Area/Ncbi/Merge">003446</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.</title><author><name sortKey="Mbeutcha, Aurelie" sort="Mbeutcha, Aurelie" uniqKey="Mbeutcha A" first="Aurélie" last="Mbeutcha">Aurélie Mbeutcha</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author><author><name sortKey="Roupret, Morgan" sort="Roupret, Morgan" uniqKey="Roupret M" first="Morgan" last="Rouprêt">Morgan Rouprêt</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Pitié-Salpétrière Hospital, APHP, University Paris VI, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Urology, Pitié-Salpétrière Hospital, APHP, University Paris VI, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Kamat, Ashish M" sort="Kamat, Ashish M" uniqKey="Kamat A" first="Ashish M" last="Kamat">Ashish M. Kamat</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Karakiewicz, Pierre I" sort="Karakiewicz, Pierre I" uniqKey="Karakiewicz P" first="Pierre I" last="Karakiewicz">Pierre I. Karakiewicz</name><affiliation wicri:level="1"><nlm:affiliation>Department of Urology, University of Montreal Health Center, Montreal, QC, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Urology, University of Montreal Health Center, Montreal, QC</wicri:regionArea><wicri:noRegion>QC</wicri:noRegion></affiliation></author><author><name sortKey="Lawrentschuk, Nathan" sort="Lawrentschuk, Nathan" uniqKey="Lawrentschuk N" first="Nathan" last="Lawrentschuk">Nathan Lawrentschuk</name><affiliation wicri:level="4"><nlm:affiliation>Department of Surgical Oncology, Peter MacCallum Cancer Centre and Department of Surgery/Olivia Newton John Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Surgical Oncology, Peter MacCallum Cancer Centre and Department of Surgery/Olivia Newton John Cancer Centre, University of Melbourne, Melbourne, VIC</wicri:regionArea><orgName type="university">Université de Melbourne</orgName><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Novara, Giacomo" sort="Novara, Giacomo" uniqKey="Novara G" first="Giacomo" last="Novara">Giacomo Novara</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Oncology, and Gastroenterology - Urology Clinic, University of Padua, Padua, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Surgery, Oncology, and Gastroenterology - Urology Clinic, University of Padua, Padua</wicri:regionArea><wicri:noRegion>Padua</wicri:noRegion></affiliation></author><author><name sortKey="Raman, Jay D" sort="Raman, Jay D" uniqKey="Raman J" first="Jay D" last="Raman">Jay D. Raman</name><affiliation wicri:level="2"><nlm:affiliation>Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Seitz, Christian" sort="Seitz, Christian" uniqKey="Seitz C" first="Christian" last="Seitz">Christian Seitz</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author><author><name sortKey="Xylinas, Evanguelos" sort="Xylinas, Evanguelos" uniqKey="Xylinas E" first="Evanguelos" last="Xylinas">Evanguelos Xylinas</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Shariat, Shahrokh F" sort="Shariat, Shahrokh F" uniqKey="Shariat S" first="Shahrokh F" last="Shariat">Shahrokh F. Shariat</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria. sfshariat@gmail.com.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna</wicri:regionArea><placeName><settlement type="city">Vienne (Autriche)</settlement><region nuts="2" type="province">Vienne (Autriche)</region></placeName></affiliation></author></analytic><series><title level="j">World journal of urology</title><idno type="eISSN">1433-8726</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age Factors</term><term>Biomarkers, Tumor (metabolism)</term><term>Carcinoma in Situ (epidemiology)</term><term>Carcinoma, Transitional Cell (epidemiology)</term><term>Carcinoma, Transitional Cell (metabolism)</term><term>Carcinoma, Transitional Cell (pathology)</term><term>Carcinoma, Transitional Cell (therapy)</term><term>Clinical Decision-Making</term><term>Disease-Free Survival</term><term>Humans</term><term>Hydronephrosis (epidemiology)</term><term>Kidney Neoplasms (epidemiology)</term><term>Kidney Neoplasms (metabolism)</term><term>Kidney Neoplasms (pathology)</term><term>Kidney Neoplasms (therapy)</term><term>Kidney Pelvis (pathology)</term><term>Kidney Pelvis (surgery)</term><term>Lymph Nodes (pathology)</term><term>Lymphatic Metastasis</term><term>Neoplasm Grading</term><term>Neoplasm Invasiveness</term><term>Neoplasm Staging</term><term>Neoplasms, Multiple Primary (epidemiology)</term><term>Neoplasms, Multiple Primary (metabolism)</term><term>Neoplasms, Multiple Primary (pathology)</term><term>Neoplasms, Multiple Primary (therapy)</term><term>Obesity (epidemiology)</term><term>Prognosis</term><term>Risk Assessment</term><term>Smoking (epidemiology)</term><term>Ureteral Neoplasms (epidemiology)</term><term>Ureteral Neoplasms (metabolism)</term><term>Ureteral Neoplasms (pathology)</term><term>Ureteral Neoplasms (therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Carcinome transitionnel ()</term><term>Carcinome transitionnel (anatomopathologie)</term><term>Carcinome transitionnel (métabolisme)</term><term>Carcinome transitionnel (épidémiologie)</term><term>Facteurs de l'âge</term><term>Grading des tumeurs</term><term>Humains</term><term>Hydronéphrose (épidémiologie)</term><term>Invasion tumorale</term><term>Marqueurs biologiques tumoraux (métabolisme)</term><term>Métastase lymphatique</term><term>Noeuds lymphatiques (anatomopathologie)</term><term>Obésité (épidémiologie)</term><term>Pelvis rénal ()</term><term>Pelvis rénal (anatomopathologie)</term><term>Prise de décision clinique</term><term>Pronostic</term><term>Stade de la tumeur</term><term>Survie sans rechute</term><term>Tabagisme (épidémiologie)</term><term>Tumeurs de l'uretère ()</term><term>Tumeurs de l'uretère (anatomopathologie)</term><term>Tumeurs de l'uretère (métabolisme)</term><term>Tumeurs de l'uretère (épidémiologie)</term><term>Tumeurs du rein ()</term><term>Tumeurs du rein (anatomopathologie)</term><term>Tumeurs du rein (métabolisme)</term><term>Tumeurs du rein (épidémiologie)</term><term>Tumeurs primitives multiples ()</term><term>Tumeurs primitives multiples (anatomopathologie)</term><term>Tumeurs primitives multiples (métabolisme)</term><term>Tumeurs primitives multiples (épidémiologie)</term><term>Épithélioma in situ (épidémiologie)</term><term>Évaluation des risques</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Biomarkers, Tumor</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Carcinome transitionnel</term><term>Noeuds lymphatiques</term><term>Pelvis rénal</term><term>Tumeurs de l'uretère</term><term>Tumeurs du rein</term><term>Tumeurs primitives multiples</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Carcinoma in Situ</term><term>Carcinoma, Transitional Cell</term><term>Hydronephrosis</term><term>Kidney Neoplasms</term><term>Neoplasms, Multiple Primary</term><term>Obesity</term><term>Smoking</term><term>Ureteral Neoplasms</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Carcinoma, Transitional Cell</term><term>Kidney Neoplasms</term><term>Neoplasms, Multiple Primary</term><term>Ureteral Neoplasms</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Carcinome transitionnel</term><term>Marqueurs biologiques tumoraux</term><term>Tumeurs de l'uretère</term><term>Tumeurs du rein</term><term>Tumeurs primitives multiples</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoma, Transitional Cell</term><term>Kidney Neoplasms</term><term>Kidney Pelvis</term><term>Lymph Nodes</term><term>Neoplasms, Multiple Primary</term><term>Ureteral Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Kidney Pelvis</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Carcinoma, Transitional Cell</term><term>Kidney Neoplasms</term><term>Neoplasms, Multiple Primary</term><term>Ureteral Neoplasms</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Carcinome transitionnel</term><term>Hydronéphrose</term><term>Obésité</term><term>Tabagisme</term><term>Tumeurs de l'uretère</term><term>Tumeurs du rein</term><term>Tumeurs primitives multiples</term><term>Épithélioma in situ</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Age Factors</term><term>Clinical Decision-Making</term><term>Disease-Free Survival</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Neoplasm Grading</term><term>Neoplasm Invasiveness</term><term>Neoplasm Staging</term><term>Prognosis</term><term>Risk Assessment</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Carcinome transitionnel</term><term>Facteurs de l'âge</term><term>Grading des tumeurs</term><term>Humains</term><term>Invasion tumorale</term><term>Métastase lymphatique</term><term>Pelvis rénal</term><term>Prise de décision clinique</term><term>Pronostic</term><term>Stade de la tumeur</term><term>Survie sans rechute</term><term>Tumeurs de l'uretère</term><term>Tumeurs du rein</term><term>Tumeurs primitives multiples</term><term>Évaluation des risques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Upper tract urothelial carcinoma (UTUC) is a rare and heterogeneous disease. Several clinical and biological prognostic factors have been identified in multi-institutional collaborative works with the aim of helping decision-making in pursuit of tailored individual patient care. This review provides an overview of these existing prognostic factors and predictive tools for the management of patients with UTUC.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27101100</PMID><DateCreated><Year>2016</Year><Month>04</Month><Day>21</Day></DateCreated><DateCompleted><Year>2017</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2017</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8726</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>3</Issue><PubDate><Year>2017</Year><Month>Mar</Month></PubDate></JournalIssue><Title>World journal of urology</Title><ISOAbbreviation>World J Urol</ISOAbbreviation></Journal><ArticleTitle>Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.</ArticleTitle><Pagination><MedlinePgn>337-353</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00345-016-1826-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Upper tract urothelial carcinoma (UTUC) is a rare and heterogeneous disease. Several clinical and biological prognostic factors have been identified in multi-institutional collaborative works with the aim of helping decision-making in pursuit of tailored individual patient care. This review provides an overview of these existing prognostic factors and predictive tools for the management of patients with UTUC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search was performed using PubMed/MEDLINE, Web of Science and Scopus databases regarding articles published in English between January 2000 and November 2015 according to PRISMA guidelines. Thresholds of 100 and 300 patients were applied for studies on biomarkers and clinical studies, respectively. All the studies on predictive tools were included for analysis. Outcomes of interest were features associated with advanced-stage UTUC, disease recurrence and survival.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 116 studies were included in this review. These large and/or multi-institutional studies have confirmed the prognostic value of standard pathological factors (i.e., tumor stage, grade and lymph node metastasis) and identified novel features such as lymphovascular invasion, tumor architecture, multifocality, concomitant CIS, variant histology and biomarker status among others. Based on these variables, several predictive tools have been developed; however, they often lack of validation. The value of these features and tools needs prospective testing.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Efforts provided by international collaboration groups have permitted to validate established features and identify new features of biologically and clinically aggressive UTUC. Further investigation on prognostic factors and biomarkers is still needed to assess the benefit of these features and tools on clinical decision-making.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mbeutcha</LastName><ForeName>Aurélie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of Nice Sophia-Antipolis, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouprêt</LastName><ForeName>Morgan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Urology, Pitié-Salpétrière Hospital, APHP, University Paris VI, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamat</LastName><ForeName>Ashish M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karakiewicz</LastName><ForeName>Pierre I</ForeName><Initials>PI</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Montreal Health Center, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawrentschuk</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, Peter MacCallum Cancer Centre and Department of Surgery/Olivia Newton John Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novara</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgery, Oncology, and Gastroenterology - Urology Clinic, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raman</LastName><ForeName>Jay D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seitz</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xylinas</LastName><ForeName>Evanguelos</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shariat</LastName><ForeName>Shahrokh F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria. sfshariat@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Weill Cornell Medical College, New York, NY, USA. sfshariat@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. sfshariat@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>World J Urol</MedlineTA><NlmUniqueID>8307716</NlmUniqueID><ISSNLinking>0724-4983</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2012 Jan;109(1):77-82</RefSource><PMID Version="1">21631698</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2012 Oct;19(11):3613-20</RefSource><PMID Version="1">22843187</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2012 Mar 13;106(6):1083-8</RefSource><PMID Version="1">22374463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2011 Aug;29(4):487-94</RefSource><PMID Version="1">21249372</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2007 Dec;52(6):1601-9</RefSource><PMID Version="1">17919807</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2011 Oct;108(8 Pt 2):E304-9</RefSource><PMID Version="1">21507184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2010 Jun;105(12):1672-7</RefSource><PMID Version="1">19912201</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol J. 2014 May 06;11(2):1435-41</RefSource><PMID Version="1">24807756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Clin Oncol. 2015 Jul;3(4):924-928</RefSource><PMID Version="1">26171208</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2009 Mar;55(3):650-7</RefSource><PMID Version="1">18584939</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2012 Nov;110(9):1325-9</RefSource><PMID Version="1">22564365</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2015 Aug;22(8):2789-98</RefSource><PMID Version="1">25564161</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2010 Jun;30(6):2439-45</RefSource><PMID Version="1">20651405</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Transl Res. 2015 Apr 15;7(4):710-22</RefSource><PMID Version="1">26064439</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2012 Jul;62(1):100-14</RefSource><PMID Version="1">22381168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2009 Feb;103(3):307-11</RefSource><PMID Version="1">18990163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2013 Aug;31(6):904-8</RefSource><PMID Version="1">21906967</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2013 May;81(5):972-7</RefSource><PMID Version="1">23523292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Oct 15;10(10):e0139624</RefSource><PMID Version="1">26469704</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2014 Mar;65(3):650-8</RefSource><PMID Version="1">24070577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2015 May;115(5):705-12</RefSource><PMID Version="1">24612074</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2015;2015:527976</RefSource><PMID Version="1">25874217</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2013 Feb;31(1):83-91</RefSource><PMID Version="1">23064982</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Oncol. 2015 Feb;20(1):156-63</RefSource><PMID Version="1">24740557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2013 Sep 3;109(5):1130-6</RefSource><PMID Version="1">23949152</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2015 Jun 2;162(11):777-84</RefSource><PMID Version="1">26030634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2011 Aug;29(4):473-80</RefSource><PMID Version="1">21499902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2014 Oct;32(7):989-1002</RefSource><PMID Version="1">25082191</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2005 Jan;173(1):56-60</RefSource><PMID Version="1">15592025</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Jpn J Clin Oncol. 2014 May;44(5):486-92</RefSource><PMID Version="1">24643292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2010 Feb;75(2):321-7</RefSource><PMID Version="1">19962727</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2010 Apr;57(4):575-81</RefSource><PMID Version="1">19959276</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2014 Nov;114(5):733-40</RefSource><PMID Version="1">24447471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2012 Oct;62(4):677-84</RefSource><PMID Version="1">22349570</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2010 Apr 28;10:164</RefSource><PMID Version="1">20426825</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2014 Jan;65(1):210-7</RefSource><PMID Version="1">22579047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can Urol Assoc J. 2014 Nov;8(11-12):E845-52</RefSource><PMID Version="1">25485014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2014 Jul;114(1):56-61</RefSource><PMID Version="1">24053463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2013 Feb;31(1):189-97</RefSource><PMID Version="1">23229227</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2011 Apr;107(7):1059-64</RefSource><PMID Version="1">20825397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2010 Jun;57(6):1072-9</RefSource><PMID Version="1">19619934</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2013 Oct;31(7):1161-5</RefSource><PMID Version="1">23415596</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2012 Nov;110(10):1426-35</RefSource><PMID Version="1">22759317</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2011 Apr;77(4):861-6</RefSource><PMID Version="1">21167566</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2013 Jun;111(8):1199-207</RefSource><PMID Version="1">23650914</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2015 May;193(5):1486-93</RefSource><PMID Version="1">25451830</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2012 Apr;61(4):818-25</RefSource><PMID Version="1">22284969</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2013 May;189(5):1662-9</RefSource><PMID Version="1">23103802</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2011 Aug;29(4):481-6</RefSource><PMID Version="1">20886219</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2011 Jul;186(1):66-72</RefSource><PMID Version="1">21571333</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2009 Feb;103(3):302-6</RefSource><PMID Version="1">18990164</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2012 Aug;62(2):224-31</RefSource><PMID Version="1">22285763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Genitourin Cancer. 2013 Sep;11(3):221-8</RefSource><PMID Version="1">23357513</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2015 Jun;67(6):1122-1133</RefSource><PMID Version="1">25488681</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2014 Nov;21(12):4041-8</RefSource><PMID Version="1">24912614</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2014 May;113(5):813-21</RefSource><PMID Version="1">24180461</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Pathol. 2013 Jul;66(7):573-82</RefSource><PMID Version="1">23539739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2012 May-Jun;30(3):252-8</RefSource><PMID Version="1">20451416</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2014 Nov;84(5):1134-40</RefSource><PMID Version="1">25443916</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Surg Oncol. 2014 Jan;40(1):113-20</RefSource><PMID Version="1">24113620</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2010 Aug;184(2):453-8</RefSource><PMID Version="1">20620397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2014 Apr;191(4):920-5</RefSource><PMID Version="1">24513163</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2012 Aug;188(2):398-404</RefSource><PMID Version="1">22698626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2010 Aug;76(2):513.e7-12</RefSource><PMID Version="1">20573388</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2010 Jun;57(6):956-62</RefSource><PMID Version="1">20018438</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2014 Jan;32(1):48.e19-26</RefSource><PMID Version="1">24055429</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2015 Nov;194(5):1449-55</RefSource><PMID Version="1">26070892</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2013 Sep;112(5):623-37</RefSource><PMID Version="1">23465088</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2016 Jan;23 (1):343-51</RefSource><PMID Version="1">26242371</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2012 Sep;30(5):666-72</RefSource><PMID Version="1">20933445</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2012 Jan 17;106(2):290-6</RefSource><PMID Version="1">22187036</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2015 May;33(5):204.e9-16</RefSource><PMID Version="1">25800374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2016 Jun;34(6):871-7</RefSource><PMID Version="1">26497969</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2016 May;195(5):1354-61</RefSource><PMID Version="1">26612196</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2016 Feb;23 (2):663-70</RefSource><PMID Version="1">26350366</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2015 Jul;194(1):223-9</RefSource><PMID Version="1">25623741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2013 Aug;49(12):2665-80</RefSource><PMID Version="1">23721778</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2011 Jul;78(1):87-92</RefSource><PMID Version="1">21601253</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2015 Oct;33(10):1439-57</RefSource><PMID Version="1">25600022</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Jpn J Clin Oncol. 2015 Dec;45(12):1175-81</RefSource><PMID Version="1">26450700</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2014 Jun;21(6):2105-12</RefSource><PMID Version="1">24492923</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2015 Dec;33(12):1965-72</RefSource><PMID Version="1">25957592</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2010 Nov;184(5):1895-900</RefSource><PMID Version="1">20846680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 2013 Jun 11;108(11):2312-20</RefSource><PMID Version="1">23674090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Anticancer Res. 2015 Sep;35(9):4829-36</RefSource><PMID Version="1">26254374</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2012 Feb;61(2):245-53</RefSource><PMID Version="1">21975249</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sci Rep. 2014 Sep 15;4:6361</RefSource><PMID Version="1">25219390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2006 Dec;98(6):1176-80</RefSource><PMID Version="1">17125474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Clin Exp Pathol. 2014 Jan 15;7(2):699-708</RefSource><PMID Version="1">24551292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Jpn J Clin Oncol. 2015 Jan;45(1):103-10</RefSource><PMID Version="1">25324479</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29</RefSource><PMID Version="1">25559415</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2014 Apr;32(2):531-7</RefSource><PMID Version="1">23907662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2007 May;177(5):1715-20</RefSource><PMID Version="1">17437794</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2011 Nov-Dec;29(6):716-23</RefSource><PMID Version="1">20056458</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2014 Jan;32(1):23.e1-8</RefSource><PMID Version="1">23403206</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Cancer Res. 2005 Apr 1;11(7):2583-90</RefSource><PMID Version="1">15814637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Histopathology. 2016 Mar;68(4):520-32</RefSource><PMID Version="1">26173071</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2015 Nov;33(11):1777-89</RefSource><PMID Version="1">25813210</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2012 Jul;110(2 Pt 2):E7-13</RefSource><PMID Version="1">22177329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2013 Nov;112(7):917-24</RefSource><PMID Version="1">23905945</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2014 Jan;191(1):28-34</RefSource><PMID Version="1">23871758</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2014 Aug;66(2):379-85</RefSource><PMID Version="1">24388440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2013 Dec;20(13):4389-96</RefSource><PMID Version="1">24046115</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2010 Aug 15;116(16):3774-84</RefSource><PMID Version="1">20564085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Cancer Res. 2015 Jul 15;5(8):2447-54</RefSource><PMID Version="1">26396920</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2015 May 09;15:380</RefSource><PMID Version="1">25956057</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2014 Apr;32(2):507-12</RefSource><PMID Version="1">23812497</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2013 Jun;63(6):1082-90</RefSource><PMID Version="1">22743166</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Metab Res Rev. 2015 Mar;31(3):307-14</RefSource><PMID Version="1">25363092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2010 Oct;58(4):574-80</RefSource><PMID Version="1">20637540</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2011 Nov-Dec;29(6):703-9</RefSource><PMID Version="1">20022267</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2012 Apr;109(8):1155-61</RefSource><PMID Version="1">21883847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2009 Nov;182(5):2177-81</RefSource><PMID Version="1">19758662</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2009 Mar 15;115(6):1224-33</RefSource><PMID Version="1">19156917</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2010 Jun;57(6):1064-71</RefSource><PMID Version="1">20071073</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urol Oncol. 2013 Aug;31(6):899-903</RefSource><PMID Version="1">21824792</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Feb 1;27(4):612-8</RefSource><PMID Version="1">19075275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 2015 Mar 15;111(4):414-22</RefSource><PMID Version="1">25488476</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2010 Jul;184(1):69-73</RefSource><PMID Version="1">20478585</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2011 Dec;60(6):1258-65</RefSource><PMID Version="1">21665356</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002278" MajorTopicYN="N">Carcinoma in Situ</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002295" MajorTopicYN="N">Carcinoma, Transitional Cell</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="N">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006869" MajorTopicYN="N">Hydronephrosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007680" MajorTopicYN="N">Kidney Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007682" MajorTopicYN="N">Kidney Pelvis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060787" MajorTopicYN="N">Neoplasm Grading</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009361" MajorTopicYN="N">Neoplasm Invasiveness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009378" MajorTopicYN="N">Neoplasms, Multiple Primary</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014516" MajorTopicYN="N">Ureteral Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Disease recurrence</Keyword><Keyword MajorTopicYN="N">Nomograms</Keyword><Keyword MajorTopicYN="N">Predictive tools</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Prognostic factors</Keyword><Keyword MajorTopicYN="N">Risk stratification</Keyword><Keyword MajorTopicYN="N">Survival</Keyword><Keyword MajorTopicYN="N">Upper tract urothelial carcinoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>04</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27101100</ArticleId><ArticleId IdType="doi">10.1007/s00345-016-1826-2</ArticleId><ArticleId IdType="pii">10.1007/s00345-016-1826-2</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Autriche</li><li>Canada</li><li>France</li><li>Italie</li><li>États-Unis</li></country><region><li>Pennsylvanie</li><li>Texas</li><li>Victoria (État)</li><li>Vienne (Autriche)</li><li>Île-de-France</li></region><settlement><li>Melbourne</li><li>Paris</li><li>Vienne (Autriche)</li></settlement><orgName><li>Université de Melbourne</li></orgName></list><tree><country name="Autriche"><region name="Vienne (Autriche)"><name sortKey="Mbeutcha, Aurelie" sort="Mbeutcha, Aurelie" uniqKey="Mbeutcha A" first="Aurélie" last="Mbeutcha">Aurélie Mbeutcha</name></region><name sortKey="Seitz, Christian" sort="Seitz, Christian" uniqKey="Seitz C" first="Christian" last="Seitz">Christian Seitz</name><name sortKey="Shariat, Shahrokh F" sort="Shariat, Shahrokh F" uniqKey="Shariat S" first="Shahrokh F" last="Shariat">Shahrokh F. Shariat</name></country><country name="France"><region name="Île-de-France"><name sortKey="Roupret, Morgan" sort="Roupret, Morgan" uniqKey="Roupret M" first="Morgan" last="Rouprêt">Morgan Rouprêt</name></region><name sortKey="Xylinas, Evanguelos" sort="Xylinas, Evanguelos" uniqKey="Xylinas E" first="Evanguelos" last="Xylinas">Evanguelos Xylinas</name></country><country name="États-Unis"><region name="Texas"><name sortKey="Kamat, Ashish M" sort="Kamat, Ashish M" uniqKey="Kamat A" first="Ashish M" last="Kamat">Ashish M. Kamat</name></region><name sortKey="Raman, Jay D" sort="Raman, Jay D" uniqKey="Raman J" first="Jay D" last="Raman">Jay D. Raman</name></country><country name="Canada"><noRegion><name sortKey="Karakiewicz, Pierre I" sort="Karakiewicz, Pierre I" uniqKey="Karakiewicz P" first="Pierre I" last="Karakiewicz">Pierre I. Karakiewicz</name></noRegion></country><country name="Australie"><region name="Victoria (État)"><name sortKey="Lawrentschuk, Nathan" sort="Lawrentschuk, Nathan" uniqKey="Lawrentschuk N" first="Nathan" last="Lawrentschuk">Nathan Lawrentschuk</name></region></country><country name="Italie"><noRegion><name sortKey="Novara, Giacomo" sort="Novara, Giacomo" uniqKey="Novara G" first="Giacomo" last="Novara">Giacomo Novara</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003446 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003446 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:27101100
|texte= Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:27101100" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |